Denny Farrar

A founding partner of Upstart Ventures in Salt Lake City, Utah, a Salt Lake City life sciences seed fund. Over the last 24 years, Mr. Farrar has co-founded 13 Salt Lake City-based life sciences companies including Myriad Genetics (Nasdaq, MYGN), a genetic and molecular diagnostics company; Acacia Biosciences, a gene profiling company merged into Rosetta Inpharmatics and acquired by Merck; Sonic Innovations, a digital hearing aid company; Q Therapeutics, a stem cell therapy company; and Sera Prognostics, a preterm birth diagnostics company. He is an attorney who has specialized in corporate law, including representation of health care companies. Mr. Farrar was a partner at the VanCott, Bagley, Cornwall & McCarthy law firm in Salt Lake City, and was previously associated with Debevoise & Plimpton in New York City and McCutcheon, Doyle, Brown & Enersen in San Francisco. He received his law degree from Stanford Law School, where he was an editor of the Law Review, and a B.A. degree in Political Science from Stanford University.